These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 17408441

  • 1. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
    Hayami J, Okamoto H, Sugihara A, Horio T.
    J Dermatol; 2007 May; 34(5):320-7. PubMed ID: 17408441
    [Abstract] [Full Text] [Related]

  • 2. Topical aminolaevulinic acid-photodynamic therapy produces an inflammatory infiltrate but reduces Langerhans cells in healthy human skin in vivo.
    Evangelou G, Farrar MD, White RD, Sorefan NB, Wright KP, McLean K, Andrew S, Watson RE, Rhodes LE.
    Br J Dermatol; 2011 Sep; 165(3):513-9. PubMed ID: 21623750
    [Abstract] [Full Text] [Related]

  • 3. Topical photodynamic therapy is immunosuppressive in humans.
    Matthews YJ, Damian DL.
    Br J Dermatol; 2010 Mar; 162(3):637-41. PubMed ID: 19863500
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
    Schacht V, Szeimies RM, Abels C.
    Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
    [Abstract] [Full Text] [Related]

  • 5. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T.
    J Immunol; 1995 Nov 01; 155(9):4207-17. PubMed ID: 7594576
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N, Hebeda KM, de Bruijn HS, Star WM.
    Photochem Photobiol; 1999 Dec 01; 70(6):921-9. PubMed ID: 10628304
    [Abstract] [Full Text] [Related]

  • 7. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
    Lang K, Schulte KW, Ruzicka T, Fritsch C.
    Skin Therapy Lett; 2001 Sep 01; 6(10):1-2, 5. PubMed ID: 11685275
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, Chiang CP.
    Lasers Surg Med; 2005 Aug 01; 37(2):114-22. PubMed ID: 16037967
    [Abstract] [Full Text] [Related]

  • 9. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
    Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM, Burg G, Binswanger U, Kempf W.
    Transplantation; 2004 Jan 15; 77(1):115-21. PubMed ID: 14724445
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
    de Bruijn HS, Sluiter W, van der Ploeg-van den Heuvel A, Sterenborg HJ, Robinson DJ.
    Photodermatol Photoimmunol Photomed; 2006 Oct 15; 22(5):238-46. PubMed ID: 16948825
    [Abstract] [Full Text] [Related]

  • 11. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER, de Vijlder HC, Sterenborg HJ, Neumann HA, Robinson DJ.
    J Eur Acad Dermatol Venereol; 2008 Apr 15; 22(4):426-30. PubMed ID: 18031503
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ, Collins P.
    Br J Dermatol; 2007 Jul 15; 157(1):87-91. PubMed ID: 17501954
    [Abstract] [Full Text] [Related]

  • 13. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
    Baptista J, Martinez C, Leite L, Cochito M.
    J Eur Acad Dermatol Venereol; 2006 Jul 15; 20(6):693-7. PubMed ID: 16836497
    [Abstract] [Full Text] [Related]

  • 14. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris.
    Hong SB, Lee MH.
    Photodermatol Photoimmunol Photomed; 2005 Dec 15; 21(6):322-5. PubMed ID: 16313244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
    Mizutani K, Watanabe D, Akita Y, Akimoto M, Tamada Y, Matsumoto Y.
    Photodermatol Photoimmunol Photomed; 2009 Oct 15; 25(5):280-2. PubMed ID: 19747250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy using a novel photosensitizer, ATX-S10(Na): comparative effect with 5-aminolevulinic acid on squamous cell carcinoma cell line, SCC15, ultraviolet B-induced skin tumor, and phorbol ester-induced hyperproliferative skin.
    Takahashi H, Nakajima S, Sakata I, Ishida-Yamamoto A, Iizuka H.
    Arch Dermatol Res; 2005 Apr 15; 296(10):496-502. PubMed ID: 15759135
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
    Takahashi H, Nakajima S, Asano R, Nakae Y, Sakata I, Iizuka H.
    J Dermatol Sci; 2012 Jun 15; 66(3):221-4. PubMed ID: 22464765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.